Generalised giant-cell tumour of bone: Successful treatment of pulmonary metastases with interferon ?, a case report

Abstract
We report on a 37-year-old female patient with generalised giant-cell tumour of the bone, whose tumour was refractory to conventional chemotherapy. Subsequent treatment with interferon α2a in increasing dosage from 4×106 IU (three times a week) to 9×106 IU (three times a week) led to a significant decrease of pulmonary metastases and a stabilisation of the disease after 12 months of treatment. In progressive chemotherapy refractory giant-cell tumour interferon α2a may be of therapeutic benefit.